Hepatitis B seroprevalence in Latin America

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 6, Issue 6, 1999, Pages 378-383

  Silveira, Thêmis R ^a   Da Fonseca, José Carlos ^b   Rivera, Luis ^c   Fay, Oscar H ^d   Tapia, Roberto ^e   Santos, José I ^e   Urdeneta, Eduardo ^f   Clemens, Sue Ann Costa ^g  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b Inst de Medicina Tropical de Manaus   (Brazil)

^c Departamento de Perinatologia   (Dominican Republic)

^d UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^e SECRETARÍA DE SALUD   (Mexico)

^f Grupo Medico Otorrinolaringologico   (Venezuela)

^g GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY;

DISEASE PREVALENCE; HEPATITIS; MEDICAL GEOGRAPHY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CENTRAL AMERICA; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEXUAL TRANSMISSION; SOUTH AMERICA; VERTICAL TRANSMISSION;

CARIBBEAN ISLANDS; CENTRAL AMERICA; SOUTH AMERICA;

EID: 0033394138     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49891999001100002     Document Type: Article

References (24)

1. Torres JR. Hepatitis B and hepatitis delta virus infection in South America. Gut 1996; 38 Suppl 2:S48-55.
2. Fay OH. Hepatitis B in Latin America: epidemiological patterns and eradication strategy. Vaccine 1990;8 Suppl:S100-106.
3. The Children's Vaccine Initiative and the Global Programme for Vaccines and Immunization. Recommendations from the Special Advisory Group of Experts. Part I. Wkly Epidemiol Rec 1996 Aug 30;71(35):261-266.
4. Bronfman M, Guiscafre H, Castro V, Castro H, Gutiérrez G. Measuring unequality: a methodological approach, analysis of social and economic characteristics of the sample studied. Archivos de Investigación Médica (Mexico) 1988;19:351-360.
5. Instituto Brasileiro de Geografia e Estatística. Características demográficas e socioeconômicas da população. In: IBGE. Anuário estatistico do Brasil. Rio de Janeiro: IBGE. 1996. p. 272-296.
6. Szmuness W, Much WM, Prince AM. On the role of sexual behavior in the spread of the hepatitis B infection. Ann Intern Med 1975; 83(4):489-495.
7. Hakre S, Reyes L, Bryan JP, Cruess D. Prevalence of hepatitis B virus among health care workers in Belize, Central America. Am J Trop Med Hyg 1995;53(2):118-122.
8. Souto FJD, Fontes CJF, Oliveria JM, Caspar AMC, Lyra LGC. Epidemiological survey of infection with hepatitis B virus in the savannah and wetlands (Pantanal) of central Brazil. Ann Trop Med Parasitol 1997;91(4):411-416
9. Bensabath BS, Boshell J. Presença do antígeno Australia em populações do interior do Estado do Amazonas, Brasil. Rev Inst Med Trop Sao Paulo 1973;15(5):284-288
10. Ferreira CRB, Yoshida CFT, Mercadante LAC, Gomes DF, Oliveria JM, Franca MS, et al. Immunization against hepatitis B in children from endemic zone: evaluation of the antibody response against DNA recombinant vaccine (Engerix B-20mcg). Rev Inst Med Trop Sao Paulo 1993;35(1):89-92.
11. Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandell GD, Benett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingston; 1995. p.1406-1439.
12. U.S. Centers for Disease Control. Enterically transmitted non-A, non-B hepatitis - Mexico. MMWR Morb Mortal Wkly Rep 1987;36(36): 597-602.
13. Bensabath G, Hadler SC, Pereira MC, et al. Hepatitis delta virus infection and Lebrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA 1987; 258(4):479-183.
14. Torres JR, Mondolfi A. Protracted outbreak of severe delta hepatitis: experience in an isolated Amerindian population in the Upper Orinoco Basin. Rev Infect Dis 1991;13(1): 52-55.
15. Hadler SC, Monzon M, Bensabath G, et al. Epidemiology of hepatitis delta virus infection in less developed countries. Prog Clin Biol Res 1991;364:21-31.
16. Popper H, Thung SN, Gerber MA, Hadler SC, de Monzon M, Ponzetto A, et al. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology 1983;3(6): 906-912.
17. Fonseca JC, Brasil LM, Braga WSM. Informe actual sobre el programa de vacunación contra el VHB en el estado de Amazonas, Brasil. Gen 1992;46:242.
18. Chunsuttiwat S, Biggs BA, Maynard J, Thamapalo S, Laoboripat S, Bovornsin S, et al. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand. Vaccine 1997;15(6-7):769-774.
19. Chainuvati T. Perspective of viral hepatitis in Thailand. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease: molecules today, more cures tomorrow. Tokyo: Springer-Verlag; 1994. p. 403-405.
20. Lolekha S. Strategies for control of hepatitis in Thailand. In: Critical issues for control of hepatitis B. Proceedings of a series of symposia, November 1989. Excerpta Medica. p. 26-29. (Asia Pacific Congress Series No 112).
21. Fay O. Implementation of hepatitis B virus vaccination in Latin America: current and future perspectives of global action. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Proceedings of the International Symposium on Viral Hepatitis and Liver Disease: molecules today, more cures tomorrow. Tokyo: Springer-Verlag; 1994. p. 522-525.
22. Bonanni P. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine 1995;13 Suppl 1:S68-71.
23. World Health Organization. Informal discussion on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine. Final report. Geneva: WHO; 1992.
24. Hadler SC. Cost benefit of combining antigens. Biologicals 1994;22(4):415-418.